The Dunn–Bonferroni post hoc test showed statistically significant differences in concentrations between the grades of glioma and how the concentrations of the proteins compared to the control group, with a clear reduction in VEGF-A concentration in CTR. This evidence concerns the gene VEGFA and central nervous system cancer.